Lina H Jandorf, MA
- PROFESSOR | Population Health Science and Policy
- PROFESSOR | Oncological Sciences
- PROFESSOR | Medicine, Gastroenterology
Lina Jandorf is the Director of Cancer Community Outreach in the Department of Oncological Sciences as well as the Director of Minority, Outreach, Recruitment and Education (MORE) for the Tisch Cancer Institute. Working with community agencies and health organizations, Ms. Jandorf is responsible for bringing cancer education and screening programs to medically underserved communities and recruiting minority residents into our research efforts. One early outcome of this work was the funding, by the National Cancer Institute, of a five year grant to develop the East Harlem Partnership for Cancer Awareness, a coalition of hospitals, community health centers, and community agencies with the common goal of increasing cancer awareness and thereby preventive care in East Harlem. In addition, Ms. Jandorf has been funded to establish the Witness Project of Harlem, a faith-based breast and cervical education program targeting African American women and Esperanza y Vida, a faith-based breast and cervical education program for Latino families. Ms. Jandorf is an active member of New York State’s Cancer Consortium Steering Committee and a member of the steering committee for New York City’s Citywide Colon Cancer Control Coalition.
In collaboration with other faculty in the Department of Oncological Sciences and with Steven Itzkowitz, M.D. (Division of Gastroenterology) she has developed a patient navigation program to increase adherence to physician recommended screening colonoscopy. These National Cancer Institute funded projects have tested different forms of navigation guidance through the medical system including peer navigators (community volunteers) who themselves have completed a colonoscopy.
Ms. Jandorf has also taken the lead in the Department of Oncological Sciences effort to establish Cancer Family Registries. These databases, specific to cancer site, include both index patients and family members. They allow us to establish the relative risk of various cancers and related disorders. In addition, the registries include information about medical practices, family history, nutrition, recreational activities, and exercise.
Ms. Jandorf also directs a number of clinical initiatives, funded through the Division of Gastroenterology (Steven Itzkowitz, M.D.), exploring new, less invasive ways to screen for colorectal cancer. These include stool-based methodologies for both average risk individuals and those at higher risk due related to Irritable Bowel Disorders (Ulcerative Colitis and Crohn's Disease).
Please visit Ms. Jandorf's Research and Outreach Programs
- Improving CRC Screening for Diverse Hispanics in an Urban Primary Care Setting
- Minority Outreach, Recruitment and Education Core (MORE)
- The Witness Project® of Harlem
- Esperanza y Vida® - The Latina Witness Project of Harlem
- Hope and Life®
- CRC Screening Thoughts and Feelings: Increasing Engagement of African Americans (Witness CARES)
- Reducing Liver Cancer Risk by Screening for Hepatitis B Virus in African-born People in the U.S.
Cancer Education and Prevention
Lina Jandorf’s research efforts are focused on reducing disparities in cancer screening, early detection, and mortality. This work has been focused on understanding cultural, interpersonal and organizational barriers to cancer screening as well as important associations between health disparities and mortality and morbidity. Through the use of Peer Lay Health Workers, her research focuses on the development and implementation of culturally and linguistically appropriate interventions to support and encourage cancer screening for medically underserved individuals. Ms. Jandorf also directs a number of clinical initiatives, funded through the Division of Gastroenterology (Steven Itzkowitz, M.D.), exploring new, less invasive ways to screen for colorectal cancer. These include stool-based methodologies for both average risk individuals and those at higher risk due related to Irritable Bowel Disorders (Ulcerative Colitis and Crohn's Disease).